The latest announcement is out from BeiGene Ltd ( (HK:6160) ).
BeiGene Ltd has announced the record date for its 2025 Annual General Meeting (AGM), set for March 26, 2025. This announcement is significant for shareholders as it outlines the eligibility criteria for attending and voting at the AGM, which is a crucial event for the company’s governance and future strategic decisions.
More about BeiGene Ltd
BeiGene Ltd is a biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drug candidates for the treatment of cancer. The company operates in the pharmaceutical industry with a market focus on oncology treatments.
YTD Price Performance: 31.23%
Average Trading Volume: 3,070,750
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: HK$210.3B
For a thorough assessment of 6160 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com